Latest News for: cov
Edit
The SAMANSIC Protocol: A Systems-Level Precision Nutrition Strategy for Post-Acute Sequelae of SARS-CoV-2 (PASC)
Ammon 14 Jul 2026
The global COVID-19 pandemic precipitated an unprecedented ...
Edit
Genomic and structural evidence of SARS-CoV-2 and MERS-CoV in migratory birds
PNAS 29 Jun 2026
Herein, we obtained three almost full-length severe acute ...
Edit
Evaluation of a proposed link between the SARS-CoV-2 furin cleavage site and mouse-adapted MERS-coronavirus MA30
PNAS 29 Jun 2026
... public commentators in support of a nonnatural origin of SARS-CoV-2.
Edit
Medical Devices: Immunology and Microbiology Devices; Classification of the SARS-CoV-2 Serology Test (The eRulemaking Program)
Public Technologies 26 Jun 2026
Medical Devices; Immunology and Microbiology Devices; Classification of the SARS-CoV-2 Serology Test ... The Food and Drug Administration (FDA) is classifying the SARS-CoV-2 serology test into class II (special controls).
Edit
GLOBAL X NASDAQ 100 COV CALL UCITS ETF Dividend Announcement 25.06.2026 (Global X ETFs ICAV)
Public Technologies 25 Jun 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 132682383) .
Edit
HKUMed–Tsinghua team develops first-in-class broad-spectrum small-molecule antiviral to combat SARS-CoV-2 and related coronaviruses (The University of Hong Kong)
Public Technologies 25 Jun 2026
) Back HKUMed-Tsinghua team develops first-in-class broad-spectrum small-molecule antiviral to combat SARS-CoV-2 and related coronaviruses ... The research team evaluated MB-32 in ACE2-transgenic mouse and hamster models of SARS-CoV-2 infection.
Edit
Extra gene coding capacity of SARS-CoV-2 provides a virus engineering platform for in vitro and ...
PNAS 24 Jun 2026
.
Edit
Compulsory vaccination against SARS-CoV-2, limited to military personnel, does not constitute discrimination under EU law (CURIA - Court of Justice of the European Union)
Public Technologies 18 Jun 2026
). The text version of this document is not available ... Attachments Permalink. Disclaimer ... (noodl.
Edit
Medical Devices: Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS-CoV-2 Viral Targets From Clinical Specimens in Near-Patient Settings (The eRulemaking Program)
Public Technologies 11 Jun 2026
Medical Devices; Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS-CoV-2 Viral Targets From Clinical Specimens in Near-Patient Settings.
Edit
mRNA delivery of a class 1/4 SARS-CoV-2 neutralizing antibody protects against diverse sarbecoviruses in a ...
PNAS 08 Jun 2026
SignificancePan-sarbecovirus broadly neutralizing antibodies (bNAbs) ...
Edit
Subsidiary Hyris awarded a public tender in Spain for the supply of SARS-CoV-2 cellular-immunity kits within a public research project (Helyx Industries SpA)
Public Technologies 08 Jun 2026
... 2 of a public tender issued by the Fundación para la Investigación Biomédica del Hospital Universitario La Paz (Madrid) for the supply of kits to determine cellular (T-cell) immunity to SARS-CoV-2.
Edit
UTMB researchers identify SARS-CoV-2 proteins that let COVID-19 outsmart the immune system (The University of Texas Medical Branch at Galveston)
Public Technologies 29 May 2026
Edit
D614G reshapes allosteric networks and opening mechanisms of SARS-CoV-2 spikes
PNAS 08 May 2026
SignificanceOur work reveals how the D614G mutation in the severe ...
- 1
- 2
- Next page »